{"disease":{"id":"pulmonary-tuberculosis-tb","name":"pulmonary tuberculosis tb"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05824871","title":"A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"Shanghai Jiatan Pharmatech Co., Ltd","has_results":false},{"nct_id":"NCT03086486","title":"Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":181,"lead_sponsor_name":"Global Alliance for TB Drug Development","has_results":true},{"nct_id":"NCT05473195","title":"A Phase 2 Trial to Evaluate the EBA, Safety and Tolerability of Eto Alone and in Combination With BVL-GSK098","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"TASK Applied Science","has_results":false},{"nct_id":"NCT03561753","title":"Pilot Clinical Trial of PRS TB Regimen I - Phase II","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":97,"lead_sponsor_name":"Shanghai Pulmonary Hospital, Shanghai, China","has_results":false},{"nct_id":"NCT07303699","title":"ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Obafemi Awolowo University Teaching Hospital","has_results":false},{"nct_id":"NCT07058233","title":"Oral Nutritional Supplementation and Weight Changes During Therapy in Malnourished Patients With Resistant Tuberculosis: A Clinical Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"RSUP Persahabatan","has_results":false},{"nct_id":"NCT07069205","title":"Breathing Exercise and Tele-Nursing Support for Patients With Tuberculosis: A Single-Group Experimental Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Canan Güngör","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}